Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction

被引:20
作者
Hoogeveen-Westerveld, Marianne [1 ]
Exalto, Carla [1 ]
Maat-Kievit, Anneke [1 ]
van den Ouweland, Ans [1 ]
Halley, Dicky [1 ]
Nellist, Mark [1 ]
机构
[1] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2010年 / 1802卷 / 09期
关键词
Tuberous sclerosis complex; TSC1; TSC2; TORC1; MISSENSE MUTATIONS; GENE-PRODUCTS; DIRECT TARGET; HAMARTIN; TUBERIN; RHEB; COMPLEX; MTOR; PHOSPHORYLATION; ACTIVATION;
D O I
10.1016/j.bbadis.2010.06.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of hamartomas in a variety of organs and tissues. The disease is caused by mutations in either the TSC1 gene on chromosome 9q34, or the TSC2 gene on chromosome 16p13.3. The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the target of rapamycin complex 1 (TORC1). Here we investigate TSC1 structure and function by analysing a series of truncated TSC1 proteins. We identify specific regions of the protein that are important for TSC1 stability, localisation, interactions and function. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 24 条
[1]   Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning [J].
Cai, SL ;
Tee, AR ;
Short, JD ;
Bergeron, JM ;
Kim, J ;
Shen, JJ ;
Guo, RF ;
Johnson, CL ;
Kiguchi, K ;
Walker, CL .
JOURNAL OF CELL BIOLOGY, 2006, 173 (02) :279-289
[2]   Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner [J].
Castro, AF ;
Rebhun, JF ;
Clark, GJ ;
Quilliam, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :32493-32496
[3]   A reliable cell-based assay for testing unclassified TSC2 gene variants [J].
Coevoets, Ricardo ;
Arican, Sermin ;
Hoogeveen-Westerveld, Marianne ;
Simons, Erik ;
van den Ouweland, Ans ;
Halley, Dicky ;
Nellist, Mark .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (03) :301-310
[4]   The tuberous sclerosis complex proteins - a GRIPP on cognition and neurodevelopment [J].
de Vries, Petrus J. ;
Howe, Christopher J. .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (08) :319-326
[5]   Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 [J].
Garami, A ;
Zwartkruis, FJT ;
Nobukuni, T ;
Joaquin, M ;
Roccio, M ;
Stocker, H ;
Kozma, SC ;
Hafen, E ;
Bos, JL ;
Thomas, G .
MOLECULAR CELL, 2003, 11 (06) :1457-1466
[6]  
Gomez MR., 1999, TUBEROUS SCLEROSIS C
[7]   Defining the role of mTOR in cancer [J].
Guertin, David A. ;
Sabatini, David M. .
CANCER CELL, 2007, 12 (01) :9-22
[8]   Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling [J].
Inoki, K ;
Li, Y ;
Xu, T ;
Guan, KL .
GENES & DEVELOPMENT, 2003, 17 (15) :1829-1834
[9]   Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment [J].
Inoki, Ken ;
Guan, Kun-Liang .
HUMAN MOLECULAR GENETICS, 2009, 18 :R94-R100
[10]  
LI Y, 2003, TRENDS BIOCHEM SCI, V28, P573